Lactococcus lactis as an adjuvant and delivery vehicle of antigens against pneumococcal respiratory infections

References

• Selwyn BJ. The epidemiology of acute respiratory tract infection in young children: comparison of findings from several developing countries. Coordinated Data Group of BOSTID Researchers. Rev Infect Dis 1990; 12:870 - 888
   PubMedGoogle Scholar
• Scott JA. The global epidemiology of childhood pneumonia 20 years on. Bull World Health Organ 2008; 86:494 - 496
   PubMed Web of Science ®Google Scholar
• Mulholland K. Childhood pneumonia mortality, a permanent global emergency. Lancet 2007; 370:285 - 289
   PubMed Web of Science ®Google Scholar
• Ruvinsky R, Gentile A, Regueira M, Corso A. Infecciones invasivas por Streptococcus pneumoniae: estudio epidemiológico e importancia del desarrollo de un sistema de vigilancia. Arch Argent Pediatr 2002; 100:31 - 43
   Google Scholar
• Michail SK, Stolfi A, Johnson T, Onady GM. Efficacy of probiotics in the treatment of pediatric atopic dermatitis: a meta-analysis of randomized controlled trials. Ann Allergy Asthma Immunol 2008; 101:508 - 516
   PubMed Web of Science ®Google Scholar
• Sanz Y, Nadal I, Sánchez E. Probiotics as drugs against human gastrointestinal infections. Recent Pat Antiinfect Drug Discov 2007; 2:148 - 156
   PubMedGoogle Scholar
• Lim IS, Lee HS, Kim WY. The effect of lactic acid bacteria isolates on the urinary tract pathogens to infants in vitro. J Korean Med Sci 2009; 24:57 - 62
   PubMed Web of Science ®Google Scholar
• Bermúdez-Humarán LG, Langella P, Cortes-Perez NG, Gruss A, Tamez-Guerra RS, Oliveira SC, et al. Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production. Infect Immun 2003; 71:1887 - 1896
   PubMed Web of Science ®Google Scholar
• Enouf V, Langella P, Commissaire J, Cohen J, Corthier G. Bovine rotavirus nonstructural protein 4 produced by Lactococcus lactis is antigenic and immunogenic. Appl Environ Microbiol 2001; 67:1423 - 1428
   PubMed Web of Science ®Google Scholar
• Miyoshi A, Poquet I, Azevedo V, Commissaire J, Bermudez-Humaran L, Domakova E, et al. Controlled production of stable heterologous proteins in Lactococcus lactis. Appl Environ Microbiol 2002; 68:3141 - 3146
   PubMed Web of Science ®Google Scholar
• Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 2005; 5:83 - 93
   PubMed Web of Science ®Google Scholar
• Vila-Córcoles A. Vaccinate your child and save its grandparents from a heart attack? Current perspectives in anti-pneumococcal vaccination. J Intern Med 21
   Google Scholar
• Fedson DS, Musher DM. Plotkin SA, Orenstein WA. Pneumococcal polysaccharide vaccine. Vaccines 2003; 4th ed Philadelphia Saunders 529 - 588
   Google Scholar
• Moberley SA, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008; 23:000422
   Google Scholar
• Lynch JP, Zhanel GG. Streptococcus pneumoniae: Epidemiology, risk factors and strategies for prevention. Semin Respir Crit Care Med 2009; 30:189 - 209
   PubMed Web of Science ®Google Scholar
• Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007; 297:1825 - 1826
   PubMed Web of Science ®Google Scholar
• Pletz MW, Maus U, Krug N, Welte T, Lode H. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species. Int J Antimicrob Agents 2008; 32:199 - 206
   PubMed Web of Science ®Google Scholar
• Katsurahara T, Hotomi M, Yamauchi K, Billal DS, Yamanaka N. Protection against systemic fatal pneumococcal infection by maternal intranasal immunization with pneumococcal surface protein A (PspA). J Infect Chemother 2008; 14:393 - 398
   PubMedGoogle Scholar
• Ogunniyi AD, Grabowicz M, Briles DE, Cook J, Paton JC. Development of a vaccine against invasive pneumococcal disease based on combination of virulence proteins of Streptococcus pneumoniae. Infect Immun 2007; 75:350 - 357
   PubMed Web of Science ®Google Scholar
• Cao J, Li D, Gong Y, et al. Caseinolytic protease: a protein vaccine which could elicit serotype-independent protection against invasive pneumococcal infection. Clin Exp Immunol 2009; 156:52 - 60
   PubMed Web of Science ®Google Scholar
• Tai SS. Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies. Crit Rev Microbiol 2006; 32:139 - 153
   PubMed Web of Science ®Google Scholar
• Fujihashi K, Koga T, van Ginkel FW, Hagiwara Y, McGhee JR. A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants. Vaccine 2002; 20:2431 - 2438
   PubMed Web of Science ®Google Scholar
• Villena J, Racedo S, Agüero G, Bru E, Medina M, Alvarez S. Lactobacillus casei improves resistance to pneumococcal respiratory infection in malnourished mice. J Nutr 2005; 135:1462 - 1469
   PubMed Web of Science ®Google Scholar
• Racedo S, Villena J, Medina M, Agüero G, Rodríguez V, Alvarez S. Lactobacillus casei administration reduces lung injuries in a Streptococcus pneumoniae infection. Microbes Infect 2006; 8:2359 - 2366
   PubMed Web of Science ®Google Scholar
• Holt PG, Strickland DH, Wikström ME, Jahnsen FL. Regulation of immunological homeostasis in the respiratory tract. Nat Rev Immunol 2008; 8:142 - 152
   PubMed Web of Science ®Google Scholar
• Lambrecht BN. Alveolar macrophage in the driver's seat. Immunity 2006; 24:366 - 368
   PubMed Web of Science ®Google Scholar
• Bergeron Y, Bergeron MG. Why does pneumococcus kill?. Can J Infect Dis 1999; 10:49 - 60
   Google Scholar
• Lambretch BN, Prins JB, Hoogsteden HC. Lung dendritic cells and host immunity to infection. Eur Respir J 2001; 18:692 - 704
   PubMed Web of Science ®Google Scholar
• Dupuis M, McDonald DM. Dendritic-cell regulation of lung immunity. Am J Respir Cell Mol Biol 1997; 17:284 - 286
   PubMed Web of Science ®Google Scholar
• Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7:145 - 173 Review
   PubMed Web of Science ®Google Scholar
• Snapper CM, Paul WE. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 1987; 236:944 - 947
   PubMed Web of Science ®Google Scholar
• Korn T, Oukka M, Kuchroo V, Bettelli E. Th17 cells: effector T cells with Inflammatory properties. Semin Immunol 2007; 19:362 - 371
   PubMed Web of Science ®Google Scholar
• Corthésy B. Recombinant immunoglobulin A: powerful tools for fundamental and applied research. Trends Biotechnol 2002; 20:65 - 71
   PubMed Web of Science ®Google Scholar
• Kiyono H, Fukuyama S. NALT- versus Peyer's-patch-mediated mucosal immunity. Nat Rev Immunol 2004; 4:699 - 710
   PubMed Web of Science ®Google Scholar
• Twigg HL. Humoral immune defense (antibodies): recent advances. Proc Am Thorac Soc 2005; 2:417 - 421
   PubMedGoogle Scholar
• Moore BB, Moore TA, Toews GB. Role of T- and B-lymphocytes in pulmonary host defences. Eur Respir J 2001; 18:846 - 856
   PubMed Web of Science ®Google Scholar
• Wells JM, Mercenier A. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nature Rev Microbiol 2008; 5:349 - 362
   Web of Science ®Google Scholar
• Gilbert C, Robinson K, Le Page RWF, Wells JM. Heterologous expression of an immunogenic pneumococcal type 3 capsular polysaccharide in Lactococcus lactis. Infect Immun 2000; 68:3251 - 3260
   PubMed Web of Science ®Google Scholar
• Nierop Groot Mn, Godefrooij J, Kleerebezem M. Heterologous expression of the pneumococcal serotype 14 polysaccharide in Lactococcus lactis requires lactococcal epsABC regulatory genes. Appl Environ Microbiol 2008; 74:912 - 915
   PubMed Web of Science ®Google Scholar
• Mierau I, Kleerebezem M. 10 years of the nisin-controlled gene expression system (NICE). Appl Microbiol Biotechnol 2005; 68:705 - 717
   PubMed Web of Science ®Google Scholar
• Boesma T, Kanninga R, Neef J, Audouy SAL, van Roosmalen ML, Steen A, et al. Novel surface display system for proteins on non-genetically modified Gram-positive bacteria. Appl Environ Microbiol 2006; 72:880 - 889
   PubMed Web of Science ®Google Scholar
• van Roosmalen ML, Kanninga R, El Khattabi M, Neef J, Audouy S, Bosma T, et al. Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria. Methods 2006; 38:144 - 149
   PubMed Web of Science ®Google Scholar
• Boersma WJA, Shaw M, Claassen E. Fuller R, Perdigón G. Probiotic bacteria as live oral vaccines Lactobacillus as the versatile delivery vehicle. Probiotics 3: Immunomodulation by the Gut Microflora and Probiotics 2000; 1st ed London Kluwer Academic Publishers 234 - 270
   Google Scholar
• Kiyono H, Fukuyama S. NALT-versus Peyer's patch mediated mucosal immunity. Nature Rev Immunol 2004; 4:699 - 710
   PubMed Web of Science ®Google Scholar
• Hussell T, Humphreys IR. Nasal vaccination induces protective immunity without immunopathology. Clin Exp Immunol 2002; 130:359 - 362
   PubMed Web of Science ®Google Scholar
• Cangemi de Gutierrez R, Santos V, Nader-Macías ME. Protective effect of intranasally inoculated Lactobacillus fermentum against Streptococcus pneumoniae challenge on the mouse respiratory tract. FEMS Immunol Med Microbiol 2001; 31:187 - 195
   PubMed Web of Science ®Google Scholar
• Mercenier A, Muller-Alouf H, Grangette C. Lactic acid bacteria as live vaccines. Curr Issues Mol Biol 2000; 2:17 - 25
   PubMedGoogle Scholar
• Mannam P, Jones KF, Geller BL. Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes. Infect Immun 2004; 72:3444 - 3450
   PubMed Web of Science ®Google Scholar
• Medina M, Villena J, Salva S, Vintiñi E, Langella P, Alvarez S. Nasal administration of Lactococcus lactis improves local and systemic immune responses against Streptococcus pneumoniae. Microbiol Immunol 2008; 52:399 - 409
   PubMed Web of Science ®Google Scholar
• Fowler NG. Antimicrobials and competitive exclusion. Int J Food Microbiol 1992; 15:277 - 279
   PubMed Web of Science ®Google Scholar
• Standford TJ, Kunkel SL, Greenberger MJ, Laichalk LL, Strieter RM. Expression and regulation of chemokines in bacterial pneumonia. J Leukoc Biol 1996; 59:24 - 28
   PubMed Web of Science ®Google Scholar
• Nelson S, Summer WR. Innate immunity, cytokines and pulmonary host defense. Infect Dis Clin North Am 1998; 12:555 - 567
   PubMed Web of Science ®Google Scholar
• Furfaro S, Berman JS, Center DM. Kradin RL, Robinson BWS. Determinants of T cell migration in the lung. Immunopathology of Lung Disease 1996; Boston: NJ Butterworth-Heinemann 15 - 32
   Google Scholar
• Mazanec MB, Kaetzel CS, Lamm ME, Fletcher D, Nedruf JG. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci USA 1992; 89:6901 - 6905
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P. Humoral immune response patterns of human mucosae: induction and relation to bacterial respiratory tract infections. J Infect Dis 1992; 165:167 - 176
   PubMed Web of Science ®Google Scholar
• Janoff EN, Fasching C, Oresnstein JM, Rubins JB, Osptad NL, Dalmasso AP. Killing of Streptococcus pneumoniae by capsular polysaccharide-specific polymeric IgA, complement and phagocytes. J Clin Invest 1999; 104:1139 - 1147
   PubMed Web of Science ®Google Scholar
• Favre L, Spertini F, Corthesy B. Secretory IgA possess intrinsic modulatory properties stimulating mucosal and systemic immune responses. J Immunol 2005; 175:2793 - 2800
   PubMed Web of Science ®Google Scholar
• García VE, Gherardi MM, Iglesias MF, Cerquetti MC, Sordelli DO. Local and systemic immunity against Streptococcus pneumoniae: Humoral responses against a non-capsulated temperature-sensitive mutant. FEMS Microbiol Lett 1993; 108:163 - 167
   PubMed Web of Science ®Google Scholar
• Miettinen M, Vuopio-Varkila J, Varkila K. Production of human tumor necrosis factor alpha, interleukin-6 and interleukin-10 is induced by lactic acid bacteria. Infect Immun 1996; 64:5403 - 5405
   PubMed Web of Science ®Google Scholar
• Blum S, Delneste Y, Alvarez S, Haller D, Pérez PF, Bode C, et al. Interactions between commensal bacteria and mucosal immunocompetent cells. Internat Dairy J 1999; 9:63 - 68
   Web of Science ®Google Scholar
• Yam KK, Pouliot P, N'diaye MM, Fournier S, Olivier M, Cousineau B. Innate inflammatory responses to the Gram-positive bacterium Lactococcus lactis. Vaccine 2008; 26:2689 - 2699
   PubMed Web of Science ®Google Scholar
• Ueda Y, Kondo M, Kelsoe G. Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J ExpMed 2005; 201:1771 - 1780
   Web of Science ®Google Scholar
• Audouy SAL, van Roosmalen ML, Neef J, Kanninga R, Post R, van Deemter M, et al. Lactococcus lactis GEM particles displaying pneumococcal antigens induce local and systemic immune responses following intranasal immunization. Vaccine 2006; 24:5434 - 5441
   PubMed Web of Science ®Google Scholar
• Tamura S, Ito Y, Asmuma H, Hirabayashi Y, Suzuki Y, Nagamine T, et al. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. J Immun 1992; 149:981 - 998
   PubMed Web of Science ®Google Scholar
• Wilschut J, de Haan A, Geerligs HJ, Huchshorn JP, van Scharrenburg GJM, Palache AM, et al. Liposomes as a mucosal adjuvant system: an intranasal liposomal influenza subunit vaccine and the role of IgA in nasal anti-influenza immunity. J Liposome Res 1994; 4:301 - 314
   Google Scholar
• Rajam G, Anderton JM, Carlone GM, Sampson JS, Ades EW. Pneumococcal surface adhesin A (PsaA): a review. Crit Rev Microbiol 2008; 34:131 - 142
   PubMed Web of Science ®Google Scholar
• Oliveira MLS, Areas APM, Campos IB, Monedero V, Perez-Martínez G, Miyaji EN, et al. Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A. Microbes Infect 2006; 8:1016 - 1024
   PubMed Web of Science ®Google Scholar
• Tu AH, Fulgham RL, McCrory MA, Briles DE, Szalai AJ. Peumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae 1999; 67:4720 - 4724
   Google Scholar
• Hanniffy SB, Carter AT, Hitchin E, Wells JM. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection. J Infect Disease 2007; 195:185 - 193
   PubMed Web of Science ®Google Scholar
• Cao J, Gong Y, Li D, Yin N, Chen T, Xu W, et al. CD4(+) T lymphocytes mediated protection against invasive pneumococcal infection induced by mucosal immunization with ClpP and CbpA. Vaccine 2009; 27:2838 - 2844
   PubMed Web of Science ®Google Scholar
• Medina M, Villena J, Vintiñi E, Hebert EM, Raya R, Alvarez S. Nasal immunization with Lactococcus lactis expressing the pneumococcal protective protein A induces protective immunity in mice. Infect Immun 2008; 76:2696 - 2705
   PubMed Web of Science ®Google Scholar
• Mawas F, Feavers IM, Corbel MJ. Serotype of Streptococcus pneumoniae capsular polysaccharide can modify the Th1:Th2 cytokine profile and IgG subclass response to pneumococcal-CRM197 conjugate vaccines in a murine model. Vaccine 2001; 19:1159 - 1166
   Web of Science ®Google Scholar
• Vintiñi E, Villena J, Alvarez S, Medina M. Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis-PppA induces effective protection against pneumoccocal infection in young mice. Clin Exp Immunol 2010; 159:351 - 362
   PubMed Web of Science ®Google Scholar
• Audouy SAL, van Selm S, van Roosmalen ML, Post E, Kanninga R, Neef J, et al. Development of lactococcal GEM-based pneumococcal vaccines. Vaccine 2007; 25:2497 - 2506
   PubMed Web of Science ®Google Scholar
• Perdigon G, Fuller R, Raya R. Lactic acid bacteria and their effect on the immune system. Curr Issues Intest Microbiol 2001; 2:27 - 42
   PubMedGoogle Scholar
• Torres Vitela MR. Flora intestinal, probióticos y salud. Formas finas, eds 2002; Guadalajara, México 119 - 132
   Google Scholar
• Alvarez S, Villena J, Racedo S, Salva S, Agüero G. Malnutrition, probiotics and respiratory infections. Research Advances in Nutrition 2007; India Global Research Network, ed. 9 - 23
   Google Scholar
• Cross M. Microbes versus microbes: immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens. FEMS Immunol Med Microbiol 2002; 34:245 - 253
   PubMed Web of Science ®Google Scholar
• Racedo S, Villena J, Medina M, Agüero G, Rodríguez V, Alvarez S. Lactobacillus casei administration reduces lung injuries in a Streptococcus pneumoniae infection. Microbes Infect 2006; 8:2359 - 2366
   PubMed Web of Science ®Google Scholar
• Alvarez S, Herrero C, Bru E, Perdigón G. Effect of Lactobacillus casei and yogurt administration on prevention of Pseudomona aeuriginosa infection in young mice. J Food Prot 2001; 64:1768 - 1774
   PubMed Web of Science ®Google Scholar
• Villena J, Racedo S, Aguero G, Bru E, Medina M, Alvarez S. Lactobacillus casei improves resistance to pneumococcal respiratory infection in malnourished mice. J Nutr 2005; 135:1462 - 1469
   PubMed Web of Science ®Google Scholar
• Villena J, Racedo S, Aguero G, Alvarez S. Yogurt accelerates the recovery of defence mechanisms against Streptococcus pneumoniae in protein malnourished mice. Br J Nutr 2006; 95:591 - 602
   PubMed Web of Science ®Google Scholar
• Salva S, Villena J, Racedo S, Alvarez S, Agüero G. Lactobacillus casei addition to a repletion diet induced early normalization of cytokine profiles during pneumococcal infection in malnourished mice. Food Agricult Immunol 2008; 19:195 - 211
   Web of Science ®Google Scholar
• Villena J, Medina M, Vintiñi E, Alvarez S. Stimulation of respiratory immunity by oral administration of Lactococcus lactis. Can J Microbiol 2008; 54:630 - 638
   PubMed Web of Science ®Google Scholar
• Salva S, Villena J, Alvarez S. Differential immunomodulatory activity of Lactobacillus rhamnosus strains isolated from goat milk: impact on intestinal and respiratory infections. Int J Food Microbiol 2009; In press
   Web of Science ®Google Scholar
• Le Loir Y, Azevedo V, Oliveira SC, Freitas DA, Miyoshi A, Bermúdez-Humarán LG, et al. Protein secretion in Lactococcus lactis: an efficient way to increase the overall heterologous protein production. Microb Cell Fact 2005; 4:2 - 9
   PubMed Web of Science ®Google Scholar
• Galdeano CM, de Moreno de LeBlanc A, Vinderola G, Bonet ME, Perdigón G. Proposed model: mechanisms of immunomodulation induced by probiotic bacteria. Clin Vaccine Immunol 2007; 14:485 - 492
   PubMed Web of Science ®Google Scholar
• Perdigon G, Alvarez S, Medina M, Vintiñi E, Roux E. Influence of the oral administration of lactic acid bacteria on IgA producing cells associated to bronchus. Int J Immunopathol Pharmacol 1999; 12:97 - 102
   PubMed Web of Science ®Google Scholar
• Perdigon G, Vintiñi E, Alvarez S, Medina M, Medici M. Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria. J Dairy Sci 1999; 82:1108 - 1114
   PubMed Web of Science ®Google Scholar
• Villena J, Medina M, Raya R, Alvarez S. Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection. Can J Microbiol 2008; 54:845 - 853
   PubMed Web of Science ®Google Scholar
• Hausdorff WP, Bryant J, Kloek C, Paradiso PR, Siber GR. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use. Clin Infect Dis 2000; 30:122 - 140
   PubMed Web of Science ®Google Scholar
• Villena J, Medina M, Racedo S, Alvarez S. Resistance of young mice to pneumococcal infection can be improved by oral vaccination with recombinant Lactococcus lactis. J Microbiol Immunol Infect 2010; 43:1 - 10
   PubMedGoogle Scholar
• Yam KK, Pouliot P, N'diaye MM, Fournier S, Olivier M, Cousineau B. Innate inflammatory responses to the Gram-positive bacterium Lactococcus lactis. Vaccine 2008; 26:2689 - 2699
   PubMed Web of Science ®Google Scholar
• Kiyono H, Fukuyama S. NALT-versus Peyer's patch mediated mucosal immunity. Nat Rev Immunol 2004; 4:699 - 710
   PubMed Web of Science ®Google Scholar
• Campos IB, Darrieux M, Ferreira DM, Miyaji EN, Silva DA, Áreas PAM, et al. Nasal immunization of mice with Lactobacillus casei expressing the pneumococcal surface protein A: induction of antibodies, complement deposition and partial protection against Streptococcus pneumoniae challenge. Microbes Infect 2008; 10:481 - 488
   PubMed Web of Science ®Google Scholar